株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のラットモデル市場の予測

Global Rat Model Market Forecast 2019-2027

発行 Inkwood Research 商品コード 513980
出版日 ページ情報 英文 130 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=110.91円で換算しております。
Back to Top
世界のラットモデル市場の予測 Global Rat Model Market Forecast 2019-2027
出版日: 2019年01月20日 ページ情報: 英文 130 Pages
概要

当レポートでは、世界のラットモデル市場について調査分析し、市場力学、セグメント別の市場分析、地域別分析、競合分析、主要企業などについて、体系的な情報を提供しています。

第1章 調査範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場決定要因

  • 市場促進要因
  • 市場抑制要因
  • 市場の機会
  • 市場の課題

第5章 市場区分

  • ラットモデルタイプ別
  • 構成要素別
  • 応用別

第6章 主要アナリティクス

  • ファイブフォースモデル
  • PESTEL分析
  • バリューチェーン分析
  • 機会マトリクス
  • 規制の枠組み
  • 推定分析
  • 主な購入基準

第7章 地域別分析

  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第8章 競合分析

  • 主な戦略と分析
  • 市場シェア
  • 上位企業分析
  • M&Aのリスト
  • 提携・パートナーシップ
  • 製品発売リスト

第9章 企業プロファイル

  • BIOMEDICAL RESEARCH MODEL INC.
  • CHARLES RIVER LABORATORIES INC.
  • COVANCE INC.
  • GENOWAY S. A.
  • HARLAN LABORATORIES, INC.
  • JANVIER LABS
  • SAGE LABS INC
  • TACONIC BIOSCIENCES
  • TRANSPOSAGEN BIOPHARMACEUTICALS INC
  • TRANSVIRAGEN INC.
  • HERA BIOLABS INC.
  • ONCODESIGN S.A.
  • CYAGEN BIOSCIENCES INC.
  • IVO BIOTECH LTD.
  • CLEA JAPAN
  • TRANSVIRAGEN, INC.
  • BIOMERE
  • LABORATORY CORPORATION OF AMERICA HOLDINGS
目次
Product Code: 5931

KEY FINDINGS

The global rat model market was worth $XX thousand in the year 2018 and is expected to grow at a CAGR of 8.08% for the forecast period of 2019-2027. It is anticipated that the market worth would be around $XX thousand by the year 2027. The main reason for the potential growth of the market is the fact that the rat models are more suitable for medical as well as pharmaceutical research as compared to other animal models used.

MARKET INSIGHTS

The global rat model market can be segmented on the basis of various categories like application, rat model types, components and rat care products. Rapid and increasing availability in transgenic rat methodologies, improving genome-editing techniques and the growing research and developments in pharmaceutical and biotechnological companies are the major drivers for the growth of the rat model market. The oncology application market is fast growing at a CAGR of xx%. However, the toxicology market is currently dominating the application segment of the market. The immunology & inflammation markets are expected to grow at a CAGR of xx% during the forecast period. With respect to the types of rat models, the current market scenario shows an anticipated CAGR of xx%, xx%, xx% and xx% respectively for the inbred rats, immune-deficient rat, surgically modified rats and hybrid type rat model. The rat care product had contributed to xx% of the market share in the year 2018 and is expected to grow at a CAGR of xx% by the year 2027.

REGIONAL INSIGHTS

The North-American rat model market is expected to hold the highest share by the year 2027 with the US market contributing to the majority of the share owing to the increased demand for rat models in the pre-clinical animal trials by companies such as Novartis, Merck & Co, Roche, etc. in this region. The Asia-Pacific market is fast flourishing, especially in regions like India, China and Australia because of the novel R&D incentive schemes for the pharmaceutical companies and the contract research organizations (CROs). The market is predicted to grow at a CAGR of xx% during the forecast period in the APAC region. The United Kingdom is currently the leader in the European rat model market mainly because of the lucrative R&D revenue schemes and the growing interest of the commercial investors in the region.

COMPETITIVE INSIGHTS

The major players in the global rat model market are Taconic Biosciences, Envigo, Laboratory Corporation of America Holdings, Transviragen Inc., Charles River Laboratories Inc., Transposagen Biopharmaceuticals Inc., Janvier Labs, Vivo Biotech Ltd., Biomere, Sage Labs Inc. (Acquired By Horizon Discovery Group PLC), Oncodesign S.A., Cyagen Biosciences Inc., Genoway S.A., Clea Japan and Hera Biolabs Inc. have the largest laboratory network around the world with most of its research focusing on genomics.

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP-DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. OUTBRED RAT TYPE HOLDS THE MAJOR SHARE IN THE RAT MODEL MARKET
    • 3.2.2. ONCOLOGY IS THE FASTEST GROWING APPLICATION
    • 3.2.3. RAT CARE PRODUCTS ARE SIGNIFICANTLY GROWING

4. MARKET DYNAMICS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVERS
    • 4.2.1. ENHANCEMENT IN GENOME EDITING
    • 4.2.2. GROWING AVAILABILITY IN RAT TRANSGENIC
    • 4.2.3. SWELLING PHARMACEUTICAL AND BIOTECHNOLOGY CORPORATIONS R&D
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. PRACTICE OF ANIMALS IN RESEARCH IS CONSIDERED UNETHICAL
    • 4.3.2. FLUCTUATING RULES AND REGULATION ON ANIMAL TESTING
    • 4.3.3. USE OF ZEBRAFISH IN RESEARCH IS THE GROWING MODEL
    • 4.3.4. IN VITRO AND ALTERNATIVE TESTING TECHNIQUES MODELS FOR RESEARCH
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. PERSONALIZED MEDICINE ESTABLISHED TO SURGE DEMAND
    • 4.4.2. ESCALATION IN MONOCLONAL ANTIBODY CREATION
  • 4.5. MARKET CHALLENGES
    • 4.5.1. HIGHLY EXPENSIVE RAT MODEL

5. MARKET BY RAT TYPE

  • 5.1. INBRED
  • 5.2. GENETICALLY ENGINEERED RATS
  • 5.3. SURGICALLY MODIFIED RATS
  • 5.4. HYBRID
  • 5.5. OUTBRED
  • 5.6. IMMUNE-DEFICIENT

6. MARKET BY APPLICATION

  • 6.1. DIABETES
  • 6.2. TOXICOLOGY
  • 6.3. ONCOLOGY
  • 6.4. IMMUNOLOGY & INFLAMMATION
  • 6.5. OTHER APPLICATION

7. MARKET BY COMPONENT

  • 7.1. TECHNOLOGY
    • 7.1.1. NUCLEAR TRANSFERASE
    • 7.1.2. MICROINJECTION
    • 7.1.3. EMBRYONIC STEM CELL INJECTION
    • 7.1.4. OTHER TECHNOLOGY
  • 7.2. SERVICES
  • 7.3. RAT CARE PRODUCTS
    • 7.3.1. FEED
    • 7.3.2. BEDDING
    • 7.3.3. CAGES
    • 7.3.4. OTHER RAT CARE PRODUCTS

8. KEY ANALYTICS

  • 8.1. PORTER'S FIVE FORCE MODEL
    • 8.1.1. THREAT OF NEW ENTRANTS
    • 8.1.2. THREAT OF SUBSTITUTE PRODUCT
    • 8.1.3. BARGAINING POWER OF BUYERS
    • 8.1.4. BARGAINING POWER OF SUPPLIERS
    • 8.1.5. INTENSITY OF COMPETITIVE RIVALRY
  • 8.2. VALUE CHAIN ANALYSIS
  • 8.3. REGULATORY FRAMEWORK
  • 8.4. KEY BUYING CRITERIA
    • 8.4.1. HIGH ACCURACY
    • 8.4.2. HIGH EFFICACY
    • 8.4.3. QUALITY OF OPERATING PROCEDURE
    • 8.4.4. PRICE
  • 8.5. OPPORTUNITY MATRIX

9. GEOGRAPHICAL ANALYSIS

  • 9.1. NORTH AMERICA
    • 9.1.1. THE UNITED STATES
    • 9.1.2. CANADA
  • 9.2. EUROPE
    • 9.2.1. THE UNITED KINGDOM
    • 9.2.2. FRANCE
    • 9.2.3. GERMANY
    • 9.2.4. SPAIN
    • 9.2.5. ITALY
    • 9.2.6. REST OF EUROPE
  • 9.3. ASIA PACIFIC
    • 9.3.1. INDIA
    • 9.3.2. CHINA
    • 9.3.3. JAPAN
    • 9.3.4. SOUTH KOREA
    • 9.3.5. AUSTRALIA
    • 9.3.6. REST OF ASIA PACIFIC
  • 9.4. REST OF WORLD
    • 9.4.1. LATIN AMERICA
    • 9.4.2. MIDDLE EAST AND AFRICA

10. COMPETITIVE LANDSCAPE

  • 10.1. MARKET POSITION ANALYSIS
  • 10.2. COMPANY PROFILES
    • 10.2.1. BIOMERE
      • 10.2.1.1. COMPANY OVERVIEW
      • 10.2.1.2. PRODUCT PORTFOLIO
      • 10.2.1.3. SCOT ANALYSIS
    • 10.2.2. CHARLES RIVER LABORATORIES INC.
      • 10.2.2.1. COMPANY OVERVIEW
      • 10.2.2.2. PRODUCT PORTFOLIO
      • 10.2.2.3. SCOT ANALYSIS
      • 10.2.2.4. STRATEGIC INITIATIVES
    • 10.2.3. CLEA JAPAN
      • 10.2.3.1. COMPANY OVERVIEW
      • 10.2.3.2. PRODUCT PORTFOLIO
      • 10.2.3.3. SCOT ANALYSIS
      • 10.2.3.4. STRATEGIC INITIATIVES
    • 10.2.4. CYAGEN BIOSCIENCES INC.
      • 10.2.4.1. COMPANY OVERVIEW
      • 10.2.4.2. PRODUCT PORTFOLIO
      • 10.2.4.3. SCOT ANALYSIS
    • 10.2.5. ENVIGO
      • 10.2.5.1. COMPANY OVERVIEW
      • 10.2.5.2. PRODUCT PORTFOLIO
      • 10.2.5.3. STRATEGIC INITIATIVES
    • 10.2.6. GENOWAY S. A.
      • 10.2.6.1. COMPANY OVERVIEW
      • 10.2.6.2. PRODUCT PORTFOLIO
      • 10.2.6.3. SCOT ANALYSIS
      • 10.2.6.4. STRATEGIC INITIATIVES
    • 10.2.7. HERA BIOLABS INC.
      • 10.2.7.1. COMPANY OVERVIEW
      • 10.2.7.2. PRODUCT PORTFOLIO
      • 10.2.7.3. SCOT ANALYSIS
      • 10.2.7.4. STRATEGIC INITIATIVE
    • 10.2.8. JANVIER LABS
      • 10.2.8.1. COMPANY OVERVIEW
      • 10.2.8.2. PRODUCT PORTFOLIO
      • 10.2.8.3. SCOT ANALYSIS
    • 10.2.9. LABORATORY CORPORATION OF AMERICA HOLDINGS
      • 10.2.9.1. COMPANY OVERVIEW
      • 10.2.9.2. PRODUCT PORTFOLIO
      • 10.2.9.3. STRATEGIC INITIATIVES
    • 10.2.10. ONCODESIGN S.A.
      • 10.2.10.1. COMPANY OVERVIEW
      • 10.2.10.2. PRODUCT PORTFOLIO
      • 10.2.10.3. SCOT ANALYSIS
      • 10.2.10.4. STRATEGIC INITIATIVE
    • 10.2.11. SAGE LABS INC. (ACQUIRED BY HORIZON DISCOVERY GROUP PLC.)
      • 10.2.11.1. COMPANY OVERVIEW
      • 10.2.11.2. PRODUCT PORTFOLIO
      • 10.2.11.3. SCOT ANALYSIS
      • 10.2.11.4. STRATEGIC INITIATIVES
    • 10.2.12. TACONIC BIOSCIENCES
      • 10.2.12.1. COMPANY OVERVIEW
      • 10.2.12.2. PRODUCT PORTFOLIO
      • 10.2.12.3. SCOT ANALYSIS
      • 10.2.12.4. STRATEGIC INITIATIVES
    • 10.2.13. TRANSPOSAGEN BIOPHARMACEUTICALS INC.
      • 10.2.13.1. COMPANY OVERVIEW
      • 10.2.13.2. PRODUCT PORTFOLIO
      • 10.2.13.3. SCOT ANALYSIS
      • 10.2.13.4. STRATEGIC INITIATIVES
    • 10.2.14. TRANSVIRAGEN INC.
      • 10.2.14.1. COMPANY OVERVIEW
      • 10.2.14.2. PRODUCT PORTFOLIO
      • 10.2.14.3. SCOT ANALYSIS
    • 10.2.15. VIVO BIOTECH LTD.
      • 10.2.15.1. COMPANY OVERVIEW
      • 10.2.15.2. PRODUCT PORTFOLIO
      • 10.2.15.3. SCOT ANALYSIS
      • 10.2.15.4. STRATEGIC INITIATIVES

TABLE LIST

  • TABLE 1 GLOBAL RAT MODEL MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 2 BENEFITS OF RAT TRANSGENIC
  • TABLE 3 GLOBAL RAT MODEL MARKET BY RAT TYPE 2019-2027 ($ MILLION)
  • TABLE 4 EXAMPLES OF INBRED RATS AND RESEARCH APPLICATIONS
  • TABLE 5 GLOBAL INBRED MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 6 GLOBAL GENETICALLY ENGINEERED RATS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 7 GLOBAL SURGICALLY MODIFIED RATS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 8 GLOBAL HYBRID MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 9 GLOBAL OUTBRED MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 10 GLOBAL IMMUNE-DEFICIENT MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 11 GLOBAL RAT MODEL MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 12 GLOBAL DIABETES MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 13 GLOBAL TOXICOLOGY MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 14 GLOBAL ONCOLOGY MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 15 GLOBAL IMMUNOLOGY & INFLAMMATION MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 16 GLOBAL OTHER APPLICATION MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 17 GLOBAL RAT MODEL MARKET BY COMPONENT 2019-2027 ($ MILLION)
  • TABLE 18 GLOBAL TECHNOLOGY MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 19 GLOBAL NUCLEAR TRANSFERASE MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 20 GLOBAL MICRO INJECTION MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 21 GLOBAL EMBRYONIC STEM CELL INJECTION MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 22 GLOBAL OTHER TECHNOLOGY MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 23 GLOBAL SERVICES MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 24 GLOBAL RAT CARE PRODUCTS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 25 GLOBAL FEED MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 26 POPULAR FOOD FOR RATS
  • TABLE 27 GLOBAL BEDDING MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 28 GLOBAL CAGES MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 29 GLOBAL OTHER RAT CARE PRODUCTS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 30 GLOBAL RAT MODEL MARKET BY GEOGRAPHY 2019-2027 ($ BILLION)
  • TABLE 31 NORTH AMERICA RAT MODEL MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 32 FUNDS ALLOCATED FOR RESEARCH ACTIVITIES IN BUDGET 2016
  • TABLE 33 EUROPE RAT MODEL MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 34 ASIA PACIFIC RAT MODEL MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 35 REST OF WORLD RAT MODEL MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 36 RAT MODEL COMPANY POSITION ANALYSIS

FIGURES LIST

  • FIGURE 1 GLOBAL RAT MODEL MARKET 2019-2027 ($ MILLION)
  • FIGURE 2 GLOBAL RAT MODEL MARKET SHARE BY RAT TYPE 2018 & 2027 (%)
  • FIGURE 3 GLOBAL RAT MODEL MARKET BY INBRED 2019-2027 ($ MILLION)
  • FIGURE 4 GLOBAL RAT MODEL MARKET BY GENETICALLY ENGINEERED RATS 2019-2027 ($ MILLION)
  • FIGURE 5 GLOBAL RAT MODEL MARKET BY SURGICALLY MODIFIED RATS 2019-2027 ($ MILLION)
  • FIGURE 6 GLOBAL RAT MODEL MARKET BY HYBRID 2019-2027 ($ MILLION)
  • FIGURE 7 GLOBAL RAT MODEL MARKET BY OUTBRED 2019-2027 ($ MILLION)
  • FIGURE 8 GLOBAL RAT MODEL MARKET BY IMMUNE-DEFICIENT 2019-2027 ($ MILLION)
  • FIGURE 9 GLOBAL RAT MODEL MARKET SHARE BY APPLICATION 2018 & 2027 (%)
  • FIGURE 10 PERCENTAGE OF DIABETES IN WORLD ADULT POPULATION IN 1980, 2015 & 2040
  • FIGURE 11 GLOBAL RAT MODEL MARKET BY DIABETES 2019-2027 ($ MILLION)
  • FIGURE 12 GLOBAL RAT MODEL MARKET BY TOXICOLOGY 2019-2027 ($ MILLION)
  • FIGURE 13 GLOBAL RAT MODEL MARKET BY ONCOLOGY 2019-2027 ($ MILLION)
  • FIGURE 14 GLOBAL RAT MODEL MARKET BY IMMUNOLOGY & INFLAMMATION 2019-2027 ($ MILLION)
  • FIGURE 15 GLOBAL RAT MODEL MARKET BY OTHER APPLICATION 2019-2027 ($ MILLION)
  • FIGURE 16 GLOBAL RAT MODEL MARKET SHARE BY COMPONENT 2018 & 2027 (%)
  • FIGURE 17 GLOBAL RAT MODEL MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
  • FIGURE 18 GLOBAL RAT MODEL MARKET BY NUCLEAR TRANSFERASE 2019-2027 ($ MILLION)
  • FIGURE 19 GLOBAL RAT MODEL MARKET BY MICRO INJECTION 2019-2027 ($ MILLION)
  • FIGURE 20 GLOBAL RAT MODEL MARKET BY EMBRYONIC STEM CELL INJECTION 2019-2027 ($ MILLION)
  • FIGURE 21 GLOBAL RAT MODEL MARKET BY OTHER TECHNOLOGY 2019-2027 ($ MILLION)
  • FIGURE 22 GLOBAL RAT MODEL MARKET BY SERVICES 2019-2027 ($ MILLION)
  • FIGURE 23 GLOBAL RAT MODEL MARKET BY RAT CARE PRODUCTS 2019-2027 ($ MILLION)
  • FIGURE 24 GLOBAL RAT MODEL MARKET BY FEED 2019-2027 ($ MILLION)
  • FIGURE 25 GLOBAL RAT MODEL MARKET BY BEDDING 2019-2027 ($ MILLION)
  • FIGURE 26 GLOBAL RAT MODEL MARKET BY CAGES 2019-2027 ($ MILLION)
  • FIGURE 27 GLOBAL RAT MODEL MARKET BY OTHER RAT CARE PRODUCTS 2019-2027 ($ MILLION)
  • FIGURE 28 PORTER'S FIVE FORCE MODEL
  • FIGURE 29 THE UNITED STATES RAT MODEL MARKET 2019-2027 ($ MILLION)
  • FIGURE 30 NATIONAL HUMAN GENOME RESEARCH BUDGET 2017 ($ MILLION)
  • FIGURE 31 CANADA RAT MODEL MARKET 2019-2027 ($ MILLION)
  • FIGURE 32 THE UNITED KINGDOM RAT MODEL MARKET 2019-2027 ($ MILLION)
  • FIGURE 33 FRANCE RAT MODEL MARKET 2019-2027 ($ MILLION)
  • FIGURE 34 GERMANY RAT MODEL MARKET 2019-2027 ($ MILLION)
  • FIGURE 35 SPAIN RAT MODEL MARKET 2019-2027 ($ MILLION)
  • FIGURE 36 ITALY RAT MODEL MARKET 2019-2027 ($ MILLION)
  • FIGURE 37 REST OF EUROPE RAT MODEL MARKET 2019-2027 ($ MILLION)
  • FIGURE 38 INDIA RAT MODEL MARKET 2019-2027 ($ MILLION)
  • FIGURE 39 CHINA RAT MODEL MARKET 2019-2027 ($ MILLION)
  • FIGURE 40 CHINESE PHARMACEUTICAL MARKET 2015 & 2020 ($ BILLION)
  • FIGURE 41 JAPAN RAT MODEL MARKET 2019-2027 ($ MILLION)
  • FIGURE 42 SOUTH KOREA RAT MODEL MARKET 2019-2027 ($ MILLION)
  • FIGURE 43 AUSTRALIA RAT MODEL MARKET 2019-2027 ($ MILLION)
  • FIGURE 44 REST OF ASIA PACIFIC RAT MODEL MARKET 2019-2027 ($ MILLION)
  • FIGURE 45 INDIA LATIN AMERICA MARKET 2019-2027 ($ MILLION)
  • FIGURE 46 MIDDLE EAST AND AFRICA RAT MODEL MARKET 2019-2027 ($ MILLION)
Back to Top